| abstract |
A pharmaceutical composition for topical use which is in the form of a water-in-oil emulsion comprising, for 100% of the weight thereof: - from 60% to 80% by weight of a gelled aqueous phase (A1) comprising an anti-inflammatory substance, - from 20% to 40% by weight of a fatty phase (A2) comprising at least one oil and an emulsifying system comprising a combination of at least one emulsifying surfactant (Si) selected from the elements of the group consisting of alkylpolyglycoside compositions and alkylpolyglycoside and fatty alcohol compositions, and of at least one emulsifying surfactant (S2) selected from the elements of the group consisting of polyglycerol esters, alkoxylated polyglycerol esters, polyglycol polyhydroxystearates, polyglycerol polyhydroxystearates and alkoxylated polyglycerol polyhydroxystearates. |